Article Versions Notes

Andrianopoulos I, Kazakos N, Lagos N, Maniatopoulou T, Papathanasiou A, Papathanakos G, Koulenti D, Toli E, Gartzonika K, Koulouras V. Co-Administration of High-Dose Nebulized Colistin for Acinetobacter baumannii Bacteremic Ventilator-Associated Pneumonia: Impact on Outcomes. Antibiotics. 2024; 13(2):169. https://doi.org/10.3390/antibiotics13020169

Andrianopoulos, Ioannis, Nikolaos Kazakos, Nikolaos Lagos, Theodora Maniatopoulou, Athanasios Papathanasiou, Georgios Papathanakos, Despoina Koulenti, Eleni Toli, Konstantina Gartzonika, and Vasilios Koulouras. 2024. "Co-Administration of High-Dose Nebulized Colistin for Acinetobacter baumannii Bacteremic Ventilator-Associated Pneumonia: Impact on Outcomes" Antibiotics 13, no. 2: 169. https://doi.org/10.3390/antibiotics13020169

Andrianopoulos, I., Kazakos, N., Lagos, N., Maniatopoulou, T., Papathanasiou, A., Papathanakos, G., Koulenti, D., Toli, E., Gartzonika, K., & Koulouras, V. (2024). Co-Administration of High-Dose Nebulized Colistin for Acinetobacter baumannii Bacteremic Ventilator-Associated Pneumonia: Impact on Outcomes. Antibiotics, 13(2), 169. https://doi.org/10.3390/antibiotics13020169